Clinical Trials Directory

Trials / Completed

CompletedNCT00932763

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects

An Open-Label, Randomized, Two-Way Crossover, Single Dose Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited, India) Compared to a 10 mg Dose of Norvasc® (Pfizer, USA) in 22 Fasted, Healthy Adult Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
Sponsor
Torrent Pharmaceuticals Limited · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers

Summary

* Objective: * The objective of this study was to assess the relative bioavailability of two formulations of immediate release amlodipine 10 mg under fasted conditions, in healthy subjects. * Study Design: * This was an open-label, single-dose, 2-treatment, 2-period, randomized, crossover study.Twenty-two healthy subjects were enrolled. Subjects who successfully completed the screening process checked into the research center the night before first dose. Subjects who continued to meet inclusion/exclusion criteria the morning of dose were assigned a subject number, based on the order in which they successfully completed the screening process and procedures as outlined in the study protocol. Subjects were randomly assigned to a treatment sequence and received two separate single-dose administrations of study medication, one treatment per period,according to the randomization schedule. Dosing days were separated by a washout period of at least 14 days. Subjects received each of the treatments listed below during the two treatment periods following an overnight fast of at least 10 hours: amlodipine by Torrent Pharmaceuticals Ltd. and Norvasc by Pfizer, Inc.

Conditions

Interventions

TypeNameDescription
DRUGAmlodipine besylate10 mg tablets (Torrent Pharmaceuticals, India)
DRUGNorvasc10 mg dose (Pfizer, USA)

Timeline

First posted
2009-07-03
Last updated
2009-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00932763. Inclusion in this directory is not an endorsement.